Table 3 Group mean scores (± SD) for per protocol assessments at baseline (mean T1, T2), T3 and T4 for the leg undergoing surgery in the APNEC (n = 9, for all time points of assessment [5 males; 4 females]) and Control (n = 12, for all time points of assessment [7 males; 5 females]) groups. Calculated effect sizes (Cohen’s d) and percentage changes are relative to baseline performance
| Â | Baseline | T3 | T4 | ES | ES |
|---|---|---|---|---|---|
Outcome |  |  |  | Baseline – T3 | Baseline – T4 |
EMDRF (ms) | |||||
 APNEC | 45.3 ± 7.2 | 33.5 ± 6.0 | 38.4 ± 7.1 | 1.78 | 0.96 |
 Control | 45.0 ± 7.7 | 43.6 ± 7.5 | 45.3 ± 7.1 | 0.20 | 0.02 |
EMDVL (ms) | |||||
 APNEC | 46.3 ± 8.1 | 33.9 ± 6.4 | 38.9 ± 8.3 | 1.70 | 0.91 |
 Control | 46.8 ± 8.1 | 45.3 ± 7.6 | 46.8 ± 7.4 | 0.20 | 0.01 |
RFD (N·s−1) | |||||
 APNEC | 578.2 ± 127.2 | 658.7 ± 143.5 | 637.2 ± 145.7 | 0.59 | 0.43 |
 Control | 605.0 ± 114.8 | 587.2 ± 128.5 | 610.5 ± 134.0 | 0.10 | 0.01 |
PF (N) | |||||
 APNEC | 182.4 ± 55.1 | 211.9 ± 62.8 | 207.1 ± 66.3 | 0.50 | 0.40 |
 Control | 171.8 ± 42.8 | 171.7 ± 44.9 | 172.8 ± 43.7 | 0.01 | 0.00 |